Target intelligence / Profile preview

KCNMB3 pseudogene 1 (KCNMB3P1)

Target: KCNMB3P1
Molecular classification: Other (transcribed unprocessed pseudogene)

Overview

KCNMB3P1 (KCNMB3 pseudogene 1), also known as KCNMB3L1, is a transcribed unprocessed pseudogene located at chromosome 22q11.1 (genomic coordinates 22:16,575,363-16,582,707)[6]. It is related by sequence to the functional gene KCNMB3, which encodes the beta-3 subunit of large conductance calcium-activated potassium channels (MaxiK/BK channels)[1][3][4]. However, KCNMB3P1 does not produce a functional protein and is not considered a receptor, enzyme, transporter, or therapeutic drug target.

Other names: KCNMB3 pseudogene 1KCNMB3L1

Beyond the preview

Go deeper on KCNMB3 pseudogene 1 (KCNMB3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KCNMB3 pseudogene 1 (KCNMB3P1).

Explore the full profile